Novonix Ltd
OTC:NVNXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novonix Ltd
OTC:NVNXF
|
AU |
|
W
|
WSFS Financial Corp
XBER:WF4
|
US |
|
F
|
FMC Corp
F:FMQ
|
US |
|
L
|
Laboratorios Farmaceuticos ROVI SA
XBER:41L
|
ES |
|
Brag House Holdings Inc
NASDAQ:HODO
|
US |
|
I
|
ioneer Ltd
NASDAQ:IONR
|
AU |
|
Lisata Therapeutics Inc
NASDAQ:LSTA
|
US |
|
Vireo Growth Inc
OTC:VREOD
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVNXF's stock price target?
Not Available
NVNXF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novonix Ltd?
Projected CAGR
776%
Over the last 2 years, the compound annual growth rate for Revenue has been -16%. The projected CAGR for the next 2 years is 776%.